Lea Ueberham

Lea Ueberham

Auto-generated profile, based on publicly available information

Lea Ueberham


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Rodrigo TeodoroRodrigo Teodoro
Rodrigo Teodoro
Daniel GuendelDaniel Guendel
Daniel Guendel
WDWinnie Deuther-Conrad
Winnie Deuther-Conrad
LULea Ueberham
Lea Ueberham
Magali ToussaintMagali Toussaint
Magali Toussaint
RMRares-Petru Moldovan
Rares-Petru Moldovan
Cannabinoid receptors type 2 (CB2R) represent an attractive therapeutic target for neurodegenerative diseases and cancer. Aiming at the development of a positron emission tomography (PET) radiotracer to monitor receptor density and/or occupancy during a CB2R-tailored therapy, we herein describe the radiosynthesis of cis-[18F]1-(4-fluorobutyl-N-((1s,4s)-4-methylcyclohexyl)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide ([18F]LU14) starting from the corresponding mesylate precursor. The first biological evaluation revealed that [18F]LU14 is a highly affine CB2R radioligand with >80% intact tracer in the brain at 30 min p.i. Its further evaluation by PET in a well-established rat model of CB2R overexpression demonstrated its ability to selectively image the CB2R in the brain and its potential as a tracer to further investigate disease-related changes in CB2R expression.